GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MyndTec Inc (XCNQ:MYTC) » Definitions » Total Receivables

MyndTec (XCNQ:MYTC) Total Receivables : C$0.01 Mil (As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is MyndTec Total Receivables?

MyndTec's Total Receivables for the quarter that ended in Sep. 2024 was C$0.01 Mil.


MyndTec Total Receivables Historical Data

The historical data trend for MyndTec's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MyndTec Total Receivables Chart

MyndTec Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Total Receivables
0.17 0.31 0.03 0.01

MyndTec Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.01 0.02 0.01 0.01

MyndTec Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables


MyndTec Total Receivables Related Terms

Thank you for viewing the detailed overview of MyndTec's Total Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


MyndTec Business Description

Traded in Other Exchanges
N/A
Address
1900 Minnesota Court, Suite 122, Mississauga, ON, CAN, L5N 3C9
MyndTec Inc is a medical technology company. It researches, develops, and distributes new therapies designed to improve function, maximize independence and enhance the quality of life for individuals with upper limb paralysis due to stroke, spinal cord injury, or traumatic brain injury. The firm develops non-invasive neurological and nervous system electrical stimulation therapeutics for the treatment of neurological diseases and injuries specifically targeted to markets with large, growing, and patient populations. The company generates revenues from sales in Canada and the United States.

MyndTec Headlines

No Headlines